An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes
- 1 January 2006
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neurology
- Vol. 253 (1) , 16-20
Abstract
Anti-CD20 monoclonal antibody (rituximab) is effectively used in the treatment of B-cell lymphomas. Recent reports in the literature suggest that antibody associated autoimmune disorders may respond to rituximab. We therefore treated nine patients with anti-Hu or anti-Yo associated paraneoplastic neurological syndromes (PNS) with a maximum of four monthly IV infusions of rituximab (375mg/m2). In this uncontrolled, unblinded trial of rituximab, three patients improved ≥1 point on the Rankin Scale (RS). One patient with limbic encephalitis improved dramatically (RS from 5 to 1). Further studies of rituximab in autoantibody associated PNS are warranted.Keywords
This publication has 23 references indexed in Scilit:
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Paraneoplastic Syndromes Involving the Nervous SystemNew England Journal of Medicine, 2003
- Treatment of IgM antibody associated polyneuropathies using rituximabJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Rituximab in the treatment of polyneuropathy associated with anti‐MAG antibodiesMuscle & Nerve, 2003
- Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisoloneJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate ReceptorNew England Journal of Medicine, 2000
- Hu antigens: Reactivity with hu antibodies, tumor expression, and major immunogenic sitesAnnals of Neurology, 1995
- Paraneoplastic cerebellar degeneration.Neurology, 1992
- Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig modelJournal of the Neurological Sciences, 1991
- Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromesNeurology, 1990